The T.J. Martell Foundation, the national non-profit charity that provides funds for innovative cancer research, will honor Universal Music Group general counsel and EVP of business and legal affairs Jeffrey Harleston and Myriad Restaurant Group founder Drew Nieporent at its 43rd annual New York Honors Gala, to be held Oct. 15 in New York.
The Honors Gala is the foundation’s primary fundraiser of the year, supporting its mission of funding innovative medical research and treatments focused on finding a cure for cancer. The gala, which will be held at Cipriani 42nd Street, will also include a reception and auction items ranging from music memorabilia, collectible wines, luxury dining and travel experiences.
Honoree Harleston is responsible for the development of corporate policies including the coordination of the company’s government relations, trade and anti-piracy activities to ensure a unified strategy across all of the company’s divisions. With over 25 years at UMG, he has held a variety of senior legal and operational positions, including executive VP/head of operations for Geffen Records and senior VP of business & legal affairs for MCA Records. Before joining Universal, Harleston was associate independent counsel during the investigation and prosecution of the Iran/Contra scandal.
Also an honoree, Nieporent is one of America’s most respected restaurateurs who is the founder and inspiration behind the Myriad Restaurant Group, which operates Tribeca Grill, Nobu Fifty Seven, Nobu Downtown, Nobu London, Bâtard, the Porsche Grille at Citi Field (home of the NY Mets), Daily Burger at Madison Square Garden and Crush Wine & Spirits. Over the last 32 years, Myriad has opened and operated over 40 restaurants around the world including San Francisco, Seattle, Louisville, Martha’s Vineyard, Boca Raton, London and Moscow. His restaurants have received countless accolades.
“The music industry’s long-time support of the T.J. Martell Foundation dates to 1975 when music executive Tony Martell established the organization in memory of his son, T.J., who was lost to leukemia at the age of 19. Since then, more than $280 million has been raised for ground-breaking treatment and support of cancer-related illnesses,” added Joel Katz, chairman of the National Board of Trustees.
For tickets, sponsorship or more information, please visit here.